삼성서울병원

Ko En

Radiation Oncology Oh, Dong Ryul M.D

Expertise
Head and neck cancer, lymphoma, esophageal cancer, digital health care
Treament Schedule 12 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
TUE
31
AM
PM
Treament Schedule 01 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

####~2017 Ph.D. Sungkunkwan university school of medicine, Korea
####~2007 M.S. Sungkunkwan university school of medicine, Korea
1997~2003 M.D. Sungkunkwan university school of medicine, Korea

Post-Graduate Training

Fellowship   2011~2013 Department of radiation oncology, Samsung medical center, Korea
Residency   2004~2008 Department of radiation oncology, Samsung medical center, Korea
Internship   2003~2004 Samsung medical Center, Korea

Professional Appointments

2018~Present Associate Professor Department of radiation oncology, Samsung medical center. Sungkyunkwan University School of Medicine
2018~Present Chief Department of radiation oncology, Samsung medical center. Korea
2014~2017 Assistant Professor Department of radiation oncology, Samsung medical center. Korea
2013~2014 Clinical Instructor Department of radiation oncology, Samsung medical center. Korea

Professional Memberships

2022~Present Board member The Korean Society of Medical Oncology
2021~Present Director at Large The Korean Society for Head & Neck Oncology
2019~Present Division Director Korean Radiation Oncology Group, Lymphoma group
2009~Present Membership The Korean Society for Radiation Oncology (KOSRO)

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • J CACHEXIA SARCOPENIA MUSCLE 2021 10.1002/jcsm.12747 Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer Yoon1, HG; Oh, D; Noh, JM; Cho, WK; Sun, JM; Kim, HK; Zo, JI; Shim, YM; Kim, K
    View PubMed
  • CANCERS 2021 10.3390/cancers13071549 Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients Yoon1, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.161 Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer Lim1, SH; Sun, JM; Hong, J; Oh, D; Ahn, YC; Chung, MK; Jeong, HS; Son, YI; Ahn, MJ; Baek, CH; Park, K
    View PubMed
  • ORAL ONCOL 2021 10.1016/j.oraloncology.2021.105180 Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients Yang1, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM
    View PubMed